[HTML][HTML] ENPP2 inhibitor improves proliferation in AOM/DSS-induced colorectal cancer mice via remodeling the gut barrier function and gut microbiota composition

J Yan, W Duan, Q Gao, T Mao, M Wang, J Duan… - Pharmacological …, 2023 - Elsevier
In our previous multicenter study, we delineated the inherent metabolic features of colorectal
cancer (CRC). Therein, we identified a member of the ectonucleotide pyrophosphatase …

[HTML][HTML] Ginsenosides Rb3 and Rd reduce polyps formation while reinstate the dysbiotic gut microbiota and the intestinal microenvironment in ApcMin/+ mice

G Huang, I Khan, X Li, L Chen, W Leong, LT Ho… - Scientific Reports, 2017 - nature.com
Studies showed that manipulation of gut microbiota (GM) composition through the treatment
of prebiotics could be a novel preventive measure against colorectal cancer (CRC) …

[HTML][HTML] Theabrownin alleviates colorectal tumorigenesis in murine AOM/DSS model via PI3K/Akt/mTOR pathway suppression and gut microbiota modulation

HKM Leung, EKK Lo, H El-Nezami - Antioxidants, 2022 - mdpi.com
Colorectal cancer (CRC) is one of the most common and fatal cancers worldwide, yet
therapeutic options for CRC often exhibit strong side effects which cause patients' well-being …

[HTML][HTML] YYFZBJS inhibits colorectal tumorigenesis by remodeling gut microbiota and influence on M2 macrophage polarization in vivo and in vitro

N Chai, Y Xiong, Y Zhang, Y Cheng, W Shi… - American Journal of …, 2021 - ncbi.nlm.nih.gov
Our previous studies indicated that the extract of Yi-Yi-Fu-Zi-Bai-Jiang-San (YYFZBJS) had
potent anticancer activities by significantly inhibiting intestinal tumor development in Apc …

[HTML][HTML] Caffeic acid phenethyl ester prevents colitis-associated cancer by inhibiting NLRP3 inflammasome

G Dai, Z Jiang, B Sun, C Liu, Q Meng, K Ding… - Frontiers in …, 2020 - frontiersin.org
Long-lasting inflammation in the intestinal tract renders individuals susceptible to colitis-
associated cancer (CAC). The NOD-like receptor protein 3 (NLRP3) inflammasome plays a …

Commensal microbiota-derived metabolite agmatine triggers inflammation to promote colorectal tumorigenesis

Y Lu, A Cui, X Zhang - Gut Microbes, 2024 - Taylor & Francis
Colorectal cancer (CRC), a malignant tumor worldwide, is associated with gut microbiota.
The influence of gut microbe-derived metabolites on CRC has attracted a lot of attention …

Arctigenin disrupts NLRP3 inflammasome assembly in colonic macrophages via downregulating fatty acid oxidation to prevent colitis-associated cancer

S Qiao, C Lv, Y Tao, Y Miao, Y Zhu, W Zhang, D Sun… - Cancer Letters, 2020 - Elsevier
Arctigenin, the major active constituent of Fructus Arctii, has been reported to inhibit the
growth of various tumors and alleviate colitis. This study aimed to prove the protective effect …

Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling

N Li, Y Xi, HN Tinsley, E Gurpinar, BD Gary, B Zhu… - Molecular cancer …, 2013 - AACR
Nonsteroidal anti-inflammatory drugs (NSAID) display promising antineoplastic activity for
colorectal and other cancers, but toxicity from COX inhibition limits their long-term use for …

The COX-2–PGE2 Pathway Promotes Tumor Evasion in Colorectal Adenomas

J Wei, J Zhang, D Wang, B Cen, JD Lang… - Cancer Prevention …, 2022 - AACR
The mechanisms underlying the regulation of a checkpoint receptor, PD-1, in tumor-
infiltrating immune cells during the development of colorectal cancer are not fully …

[HTML][HTML] An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis

MC Lu, JA Ji, YL Jiang, ZY Chen, ZW Yuan, QD You… - Scientific Reports, 2016 - nature.com
Ulcerative colitis (UC) is a chronic relapsing-remitting form of inflammatory bowel disease
(IBD) that increases the risk of colorectal cancer, the third most common malignancy in …